J.E. Nash
Toronto Western Research Institute
Toronto Western Hospital
Toronto
Ontario
Canada
Name/email consistency: high
- Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia. Nash, J.E., Johnston, T.H., Collingridge, G.L., Garner, C.C., Brotchie, J.M. FASEB J. (2005)
- The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease. Nash, J.E., Ravenscroft, P., McGuire, S., Crossman, A.R., Menniti, F.S., Brotchie, J.M. Exp. Neurol. (2004)